Position in TLRY
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$94,093
New position
Shares Held
14,543
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026R Squared Ltd holds $1,106,158 across 6 Drug Manufacturers - Specialty & Generic names. TLRY ranks #3 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIK |
Anika Therapeutics, Inc.
|
50,184 | $727,668 | |
| 2 | HLN |
Haleon plc
|
12,473 | $124,854 | |
| 3 | TLRY |
Tilray Brands, Inc.
This page
|
14,543 | $94,093 | |
| 4 | XERS |
Xeris Biopharma Holdings, Inc.
|
13,802 | $80,051 | |
| 5 | TKNO |
Alpha Teknova, Inc.
|
14,376 | $41,546 | |
| 6 | ADCT |
ADC Therapeutics SA
|
10,119 | $37,946 |
All Filings in TLRY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $94,093 | 14,543 | Shares | Sole | 2026-04-29 | |
| No filing history on record for this holder in this stock. | ||||||